Article
Influence of Cytochrome P450, ABC and SLC Gene Polymorphisms on Imatinib Therapy Outcome of Patients with Gastrointestinal Stromal Tumours (GIST).
Folia biologica - 1 Jan 2017
Wasielewski K, Wasag B, Wozniak A, Pikiel J, Kowalik A, Osuch C, Bylina E, Siedlecki J A, Rutkowski P, Limon J
Abstract excerpt
The efficacy of imatinib-based therapy depends on the proteins involved in its metabolism and transportation. Therefore, the aim of our study was to investigate the possible correlation of selected P450, ABC and SLC polymorphic variants and the outcome of imatinib therapy. A total of 101 patients with advanced, KIT/PDGFRA(+) GIST treated with imatinib were enrolled to the study. DNA was extracted from peripheral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
